Charlotte Graham

Charlotte Graham

King's College

H-index: 9

North America-United States

About Charlotte Graham

Charlotte Graham, With an exceptional h-index of 9 and a recent h-index of 9 (since 2020), a distinguished researcher at King's College, specializes in the field of Haematology, immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood

P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma

Four challenges to CAR T cells breaking the glass ceiling

Clinical pharmacology and determinants of response to UCART19, an allogeneic anti-CD19 CAR-T cell product, in adult B-cell acute lymphoblastic leukemia

Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel

Charlotte Graham Information

University

Position

___

Citations(all)

719

Citations(since 2020)

702

Cited By

203

hIndex(all)

9

hIndex(since 2020)

9

i10Index(all)

9

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Charlotte Graham Skills & Research Interests

Haematology

immunotherapy

Top articles of Charlotte Graham

Optimization of a flow cytometry test for routine monitoring of B cell maturation antigen targeted CAR in peripheral blood

Cytometry Part B: Clinical Cytometry

2024/2/28

P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA

HemaSphere

2023/8/1

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

The Journal of clinical investigation

2023/7/3

Chemotherapy-induced reversal of ciltacabtagene autoleucel-associated movement and neurocognitive toxicity

Blood

2023/10/5

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma

Nature Communications

2023/11/18

Four challenges to CAR T cells breaking the glass ceiling

2023/11

Charlotte Graham
Charlotte Graham

H-Index: 7

Marcela V Maus
Marcela V Maus

H-Index: 48

Clinical pharmacology and determinants of response to UCART19, an allogeneic anti-CD19 CAR-T cell product, in adult B-cell acute lymphoblastic leukemia

Cancer Research Communications

2022/11/30

Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel

Blood

2022/11/15

CAR T Cells Contend with Myeloma in the Bone Marrow Microenvironment

Blood Cancer Discovery

2022/11/2

301 Single-cell RNA study of transcriptional activities associated with anakinra prophylaxis and axicabtagene ciloleucel in patients with relapsed or refractory large B-cell …

2022/11/1

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a …

The Lancet Haematology

2022/11/1

Allogeneic anti-BCMA CAR T cells are superior to multiple myeloma-derived CAR T cells in preclinical studies and may be combined with gamma secretase inhibitors

Cancer Research Communications

2022/3/23

Charlotte Graham
Charlotte Graham

H-Index: 7

Reuben Benjamin
Reuben Benjamin

H-Index: 16

Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma

Leukemia

2021/12

Stroma-immune landscape in lymphoma: new mechanisms of immunosuppression and therapeutic targeting

Cancer Research

2021/7/1

Evaluating the immunological characteristics and anti-tumour efficacy of healthy donor and patient derived CD19 targeted chimeric antigen receptor T cells in B cell malignancies

2021

Charlotte Graham
Charlotte Graham

H-Index: 7

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

The Lancet

2020/12/12

COVID-19 in patients with sickle cell disease–a case series from a UK tertiary hospital

Haematologica

2020/11/11

Charlotte Graham
Charlotte Graham

H-Index: 7

David Rees
David Rees

H-Index: 1

See List of Professors in Charlotte Graham University(King's College)